Celldex (CLDX) Misses Q3 EPS by 11c

Celldex (NASDAQ: CLDX) reported Q3 EPS of ($1.01), $0.11 worse than the analyst estimate of ($0.90).

For earnings history and earnings-related data on Celldex (CLDX) click here.

You May Also Be Interested In

• Morgan Stanley Assumes Prada SpA (1913:HK) (PRDSY) at Equalweight
• Nomura/Instinet Reiterates Buy Rating on Dr. Reddy\'s Laboratories (DRRD:IN) (RDY)
• Jefferies Upgrades Mercedes-Benz Group (MBG:GR) (DDAIF) to Buy